tiprankstipranks
CytoSorbents sees Q4 product revenue $9M-$9.2M vs. $7.35M last year
PremiumThe FlyCytoSorbents sees Q4 product revenue $9M-$9.2M vs. $7.35M last year
28d ago
Cytosorbents Initiates Rights Offering to Raise Capital
Premium
Company Announcements
Cytosorbents Initiates Rights Offering to Raise Capital
1M ago
CytoSorbents commences Rights Offering
Premium
The Fly
CytoSorbents commences Rights Offering
1M ago
CytoSorbents reports Q3 adjusted EPS (8c), consensus (6c)
PremiumThe FlyCytoSorbents reports Q3 adjusted EPS (8c), consensus (6c)
3M ago
Is CTSO a Buy, Before Earnings?
Premium
Pre-Earnings
Is CTSO a Buy, Before Earnings?
3M ago
CytoSorbents submits Health Canada MDL application for DrugSorb ATR
Premium
The Fly
CytoSorbents submits Health Canada MDL application for DrugSorb ATR
3M ago
CytoSorbents appoints Peter Mariani as Chief Financial Officer
PremiumThe FlyCytoSorbents appoints Peter Mariani as Chief Financial Officer
6M ago
CytoSorbents reports Q2 EPS (8c), consensus (10c)
Premium
The Fly
CytoSorbents reports Q2 EPS (8c), consensus (10c)
6M ago
CytoSorbents Regains Compliance, Continues on Nasdaq
Premium
Company Announcements
CytoSorbents Regains Compliance, Continues on Nasdaq
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100